Drug & intervention

bismuth subsalicylate 262 MG Oral Tablet [Kaopectate Reformulated Aug 2006]

RxCUI 642349

What this record represents

SBD · RxNorm

This is an RxNorm SBD drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.

What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.

Inspect the RxNorm source identifier

Related drug records

RxNorm name matches

These are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.

Molecular structure

Active ingredient: bismuth subsalicylate
Molecular structure illustration of bismuth subsalicylate
RxNorm RxCUI 19478 · PubChem CID 53629521 · C7H5BiO4. Verify structure at PubChem. This drawing represents the matched chemical ingredient, not necessarily a complete multi-ingredient branded product.
Clinical trials0
Recruiting0
Related conditions0
Synonyms4
Advertisement

Active ingredients and chemical structures

RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.

2D chemical structure of bismuth subsalicylate bismuth subsalicylate RxCUI 19478 · Ingredient View ingredient recordPubChem CID 53629521

Conditions being studied

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.